| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 09/23/2010 | US20100240743 Cannabinoid receptor modulator |
| 09/23/2010 | US20100240729 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same |
| 09/23/2010 | US20100240722 Fluorine-containing organosulfur compound and pesticidal composition comprising the same |
| 09/23/2010 | US20100240720 Allosteric jnk inhibitors |
| 09/23/2010 | US20100240717 Novel thiophene derivatives as s1p1/edg1 receptor agonists |
| 09/23/2010 | US20100240713 Aromatic and heteroaromatic compounds useful in treating iron disorders |
| 09/23/2010 | US20100240708 Alpha-(N-Benzenesulfonamido)Cycloalkyl Derivatives |
| 09/23/2010 | US20100240678 Leukotriene b4 inhibitors |
| 09/23/2010 | US20100240677 Compounds as PDE IV and TNF Inhibitors |
| 09/23/2010 | US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase |
| 09/23/2010 | US20100240617 Bicyclic sphingosine 1-phosphate analogs |
| 09/23/2010 | US20100237334 Benzo-Fused Thiophene or Bezon-Fused Furan Compounds Comprising a Triphenylene Group |
| 09/23/2010 | CA2755526A1 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics |
| 09/22/2010 | EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 09/22/2010 | EP2229374A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors |
| 09/22/2010 | EP2229373A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
| 09/22/2010 | CN101842364A Sulfamide derivative useful for the treatment of epilepsy |
| 09/22/2010 | CN101842358A Fluorine-containing organosulfur compound and pesticidal composition comprising the same |
| 09/22/2010 | CN101838259A Sulfonium salts useful as cationic photoinitiators in energy-curable compositions and processes of preparing cured polymeric compositions |
| 09/21/2010 | US7799952 contacting with L-(-)-di-O-benzoyl-L-(-)-tartaric acid (L-(-)-DBTA) to form salt, then contacting solution with achiral mineral acid, followed by separation |
| 09/21/2010 | US7799935 Crystalline duloxetine hydrochloride |
| 09/21/2010 | US7799825 such as 3-[5-(Trifluoroacetyl)-2-thienyl]benzoic acid, useful as antiproliferative and ancarcinogenic agents, and for treating neurodegenerative diseases, schizophrenia, inflammatory diseases, restenosis, immune disorders, diabetes, cardiovascular disorders, asthma, brain and psychological disorders |
| 09/21/2010 | US7799786 Therapeutic agents useful for treating pain |
| 09/21/2010 | US7799524 methods of transferring a label from novel substrates to O6-alkylguanine-DNA alkyltransferases (AGT) and O6-alkylguanine-DNA alkyltransferase fusion proteins, and to novel substrates suitable in such methods |
| 09/21/2010 | CA2594221C Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same |
| 09/21/2010 | CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 09/21/2010 | CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2010 | WO2010104131A1 Conjugated compound, and organic thin film and organic thin film element each comprising same |
| 09/16/2010 | WO2010104118A1 Branched compound, and organic thin film and organic thin film element each comprising same |
| 09/16/2010 | WO2010103443A1 A process for the preparation of duloxetine hydrochloride |
| 09/16/2010 | WO2010103115A1 Process for preparing brinzolamide |
| 09/16/2010 | US20100234620 Process for preparing n-methyl-n-hydroxyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine derivative |
| 09/16/2010 | US20100234619 Preparation of (s)-(+)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl) propylamine using optically active methylhydroxylaminopropanol derivative as an intermediate |
| 09/16/2010 | US20100234350 Platelet adp receptor inhibitors |
| 09/16/2010 | US20100233106 Small-molecule modulators of melanin expression |
| 09/16/2010 | US20100230659 Optical Devices and Their Manufacture |
| 09/16/2010 | CA2754141A1 A process for the preparation of duloxetine hydrochloride |
| 09/15/2010 | EP2228372A1 Process for Preparing (S)-(+)-N-Methyl-3-(1-Naphthyloxy)-3-(2-Thienyl-Propylamine by using Optically Active Methylhydroxylaminopropanol Compound as an Intermediate |
| 09/15/2010 | EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 09/15/2010 | EP2227453A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 09/15/2010 | CN101835874A Luminescent-element material and luminescent element |
| 09/15/2010 | CN101835770A Condensed compounds with activity at estrogen receptors |
| 09/15/2010 | CN101829602A Catalytic system for preparing N-Boc-aromatic amine compounds and preparation method and application thereof |
| 09/15/2010 | CN101098863B Method for purifying (1s)-3-methylamino-1-(2-thienyl)-1-propanol |
| 09/14/2010 | US7795456 Insecticidal N-substituted sulfoximines |
| 09/14/2010 | US7795455 Crystalline duloxetine hydrochloride |
| 09/14/2010 | US7795454 dissolving duloxetine in a first organic solvent (e.g.ethyl acetate) to form a first solution; adding the first solution to a second organic solvent (e.g.ethanol) comprising HCl to form a second solution;allowing duloxetine hydrochloride to crystallize out from second solution; collecting the product |
| 09/14/2010 | US7795453 6-[(Anilinocarbonyl)amino]-N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-1-benzothiophene-2-carboxamide hydrochloride; treatment of dementia, attention deficit hyperactivity disorder and impairments of learning and memory |
| 09/14/2010 | US7795315 N-(2-amino-phenyl)-amide derivatives |
| 09/14/2010 | CA2479353C N-substituted benzothiophenesulfonamide derivative |
| 09/14/2010 | CA2422805C Retinoids for the treatment of emphysema |
| 09/14/2010 | CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase |
| 09/14/2010 | CA2394276C Serine protease inhibitors |
| 09/10/2010 | WO2010101224A1 Organic semiconductor material and organic thin film transistor |
| 09/10/2010 | WO2010100990A1 Process for the production of nucleophilic adducts by grignard reaction, and nucleophilic addition reactant |
| 09/10/2010 | WO2010099853A1 Thiophene derivates and liquid crystal media comprising the same |
| 09/10/2010 | WO2010099583A1 Photosensitive optoelectronic devices comprising polycyclic aromatic compounds |
| 09/09/2010 | US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
| 09/09/2010 | US20100227898 Novel microbiocides |
| 09/08/2010 | EP1475383B1 Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers |
| 09/08/2010 | CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 09/08/2010 | CN101827854A Transition metal complex and process for producing conjugated aromatic compound with the transition metal complex |
| 09/08/2010 | CN101827834A Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group |
| 09/08/2010 | CN101827817A Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 09/08/2010 | CN101827813A Sulfone compound, sulfonic acid salt, and radiation-sensitive resin composition |
| 09/08/2010 | CN101824043A Compositions useful as inhibitors of protein kinases |
| 09/08/2010 | CN101824025A Sulfur-containing diterpene compound, preparation method and medicament combination |
| 09/08/2010 | CN101824024A Method for synthesizing strontium ranelate |
| 09/07/2010 | US7790900 such as 1-amino-2-phenylpropane by reacting unsaturated nitroolefin with organosilicon compounds such as poly(methylhydrosiloxane) and phenylsilane, in presence of asymmetric copper complex having phosphine ligand |
| 09/07/2010 | US7790758 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide; stereoselectively epoxidising a suitable styrene; coupling with boronic acid derivatives |
| 09/07/2010 | US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa |
| 09/07/2010 | CA2509218C 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists |
| 09/07/2010 | CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/07/2010 | CA2370344C Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
| 09/02/2010 | WO2010098866A1 Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors |
| 09/02/2010 | WO2010098326A1 Novel compounds, process for preparing same, organic semiconductor materials, and organic semiconductor devices |
| 09/02/2010 | WO2010098193A1 β-AMINOCARBONYL COMPOUND MANUFACTURING METHOD AND LITHIUM BINAPHTHOLATE COMPLEXES |
| 09/02/2010 | WO2010097374A1 Compounds for use as bradykinin b1 antagonists |
| 09/02/2010 | WO2010036497A3 Selective estrogen repector modulator for the treatment of osteoarthritis |
| 09/02/2010 | US20100222602 Crystalline rotigotine base and preparation process therefor |
| 09/02/2010 | US20100222601 Synthesis of cyclopentadiene derivatives |
| 09/02/2010 | US20100222389 Novel microbiocides |
| 09/02/2010 | US20100222381 Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors |
| 09/02/2010 | US20100222380 Modified Chalcone Compounds as Antimitotic Agents |
| 09/02/2010 | US20100222330 New Compounds |
| 09/02/2010 | DE102010008132A1 Thiophen-Verbindungen für flüssigkristalline Medien Thiophene compounds for liquid crystalline media |
| 09/01/2010 | EP2223918A1 Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element |
| 09/01/2010 | EP2223910A1 Oxime esters and photopolymerization initiators containing the same |
| 09/01/2010 | EP1979322B1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 09/01/2010 | EP1255543B1 Use of retinoid-type compounds as antibacterial agents against staphylococcus aureus |
| 09/01/2010 | EP1028942B1 Dipeptide nitriles |
| 09/01/2010 | CN1948298B Dopamine D3 acceptor portion agonist and its application |
| 09/01/2010 | CN1706841B 1-(4,4-diaryl-3-butene)-piperidine formic acid or its medicine salt, preparation process and application |
| 09/01/2010 | CN101821250A Novel thiophene-based dye and preparation thereof |
| 09/01/2010 | CN101818056A Dansyl molecular probe and synthetic method and application thereof |
| 09/01/2010 | CN101817811A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms |
| 09/01/2010 | CN101817810A Method for manufacturing acyl compounds |
| 08/31/2010 | US7786328 e.g. benzoic acid 2-[4-dimethylamino-4-(3-methyl-benzyl)-cyclohexylcarbamoyl]-benzyl ester; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases |
| 08/31/2010 | US7786311 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/31/2010 | US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example |